People · Operator
Named in public records as an officer, director or promoter · active 2019–2026 · Medical Devices, Other Technology, Other Health Care, Space / Aerospace, Hospitals and Physicians
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Surgical Center of Greensboro, LLC | — | Medical Devices | Series A | $12.4M | $2.9M | 2025 |
| VIQ Solutions Inc. | — | Other Technology | Series A | $8.2M | $7.6M | 2019 |
| Danbury Surgical Center Lp | — | Medical Devices | Seed | $6.2M | $690K | 2026 |
| B R A S S Partnership In Commendam | — | Other Health Care | Pre-Seed | $3.8M | $607K | 2026 |
| Colonial Outpatient Surgery Center, LLC | — | Other Health Care | Pre-Seed | $1.3M | $1.4M | 2025 |
| Panama City Surgery Center, LLC | — | Other Health Care | Pre-Seed | $1.3M | $852K | 2025 |
| Volatus Aerospace Inc. | — | Space / Aerospace | Pre-Seed | $1.0M | $1.9M | 2025 |
| CTVSA Holdings, LLC | — | Hospitals and Physicians | Pre-Seed | $821K | $2.5M | 2025 |
Larry Taylor at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Larry Taylor on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Richard L. Sharff, Jr. | 3 | 72 |
| Andrew P. Hayek | 3 | 65 |
| Joseph T. Clark | 3 | 63 |
| Daniel Riggs | 3 | 7 |
| Jordan Jones | 2 | 44 |
| Steven J. Hutkai | 2 | 39 |
| Jody B. Martin | 2 | 36 |
| PATRICK WALKER | 2 | 33 |
| Ladd Mark | 2 | 30 |
| John Walker | 2 | 17 |
| Michael A. Rucker | 1 | 40 |
| Ladd W. Mark | 1 | 33 |
| Michael L. Rucker | 1 | 19 |
| Peter A. Clemens | 1 | 16 |
| Andrew Hayek | 1 | 13 |
| Thomas L. De Weerdt | 1 | 13 |
| Peter L. Clemens | 1 | 12 |
| Jordan W. Jones | 1 | 9 |
| Patrick Neil Walker | 1 | 9 |
| Peter T. Clemens | 1 | 8 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.